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Purpose: Data on the incidence of, risk factors for, and association with outcomes of acute 
kidney injury (AKI) after pediatric liver transplantation are scarce. We conducted a 
retrospective cohort study to determine the incidence of AKI after pediatric liver 
transplantation. In addition, we examined risk factors for AKI and association of AKI with 
outcomes. 
Methods: This study included 156 children aged between 3 months and 18 years undergoing 
liver transplantation at Kyoto University Hospital. AKI was defined according to the Kidney 
Disease: Improving Global Outcomes guidelines based on serum creatinine and urine output. 
We used multivariable logistic regression with stepwise variable selection to identify 
independent risk factors for AKI. 
Results: AKI occurred in 72 patients (46.2%); 34 (21.8%) had Stage 1, 32 (20.5%) had Stage 
2, and 6 (3.8%) had Stage 3 AKI. Factors independently associated with the development of 
AKI were increased preoperative total bilirubin level (adjusted odds ratio: 1.04 per 1 mg/dL; 
95% confidence interval: 1.01–1.09; P = 0.026) and increased intraoperative blood loss 
(adjusted odds ratio: 1.03 per 10 mL/kg; 95% confidence interval: 1.00–1.06; P = 0.022). AKI 
was significantly associated with prolonged hospitalization (median: 61 vs. 46 days; P = 
0.028). In-hospital mortality rate was 4.2% in patients with AKI and 3.6% in those without (P 
= 1.000). 
Conclusion: The incidence of AKI after pediatric liver transplantation was 46.2%. Increased 
preoperative total bilirubin level and increased intraoperative blood loss were independently 





Previous studies involving adults have shown that acute kidney injury (AKI) is common after 
liver transplantation and may lead to serious complications including the development of 
chronic kidney disease and increased mortality [1–3]. A single-center study involving 424 
adult liver transplant recipients [3] used the Kidney Disease: Improving Global Outcomes 
criteria to define postoperative AKI and reported that AKI occurred in 52% of patients and 
the development of AKI negatively impacted short-term and long-term graft survival. Many 
patient- and procedure-related risk factors for AKI after adult liver transplantation have been 
identified, including female gender [3], obesity [3,4], preoperative chronic kidney disease 
[5,6], diabetes mellitus [1,7,8], high model for end-stage liver disease score [4,8–12], high 
Child–Pugh score [3], and large amount of blood loss [6,9,13]. These findings may help 
identify patients at a high risk for AKI and improve perioperative management to prevent or 
ameliorate AKI. 
However, in contrast to adult liver transplantation, data on the incidence of, risk factors for, 
and association with outcomes of AKI in pediatric liver transplant recipients are scarce. 
Because adults and children differ in terms of the etiology of liver disease, coexisting 
conditions, and reserve capacity of the kidney, the epidemiologic features of AKI after 
pediatric liver transplantation may differ from those after adult liver transplantation. 
Therefore, we conducted a retrospective cohort study to determine the incidence of AKI after 
pediatric liver transplantation. We hypothesized that AKI would be common among pediatric 
liver transplant recipients. In addition, we investigated the risk factors for AKI and 





The ethics committee of Kyoto University Hospital approved this single-center retrospective 
study (approval number: R0060; April 14, 2016) and waived the requirement for informed 
consent. We included patients aged between 3 months and 18 years who underwent liver 
transplantation at Kyoto University Hospital from January 2006 to March 2015. Patients who 
had end-stage renal disease preoperatively (patients having an estimated glomerular filtration 
rate of <35 mL/min/1.73 m2, as determined using the modified Schwartz equation [14], or 
those undergoing hemodialysis within 2 weeks prior to the surgery) were excluded because 
AKI assessment was no longer relevant. 
 
Perioperative management 
At our institution, anesthetic drugs used for liver transplantation are standardized; anesthesia 
was induced using propofol (1–1.5 mg/kg) and remifentanil (0.1 µg/kg/min), and maintained 
using sevoflurane (1%–1.5%) and remifentanil (0.1–0.3 µg/kg/min). During the surgery, red 
blood cell concentrate was administered to maintain a hematocrit of 25%–30%. Although use 
of vasopressors was decided by the attending anesthesiologist, the first-line vasopressor used 
during the surgery was phenylephrine. If phenylephrine was ineffective, dopamine, 
norepinephrine, vasopressin, or epinephrine was considered. 
Immunosuppression was provided according to the institutional protocol, as previously 
described [15]. The basic immunosuppressive regimen comprised a calcineurin inhibitor 
(tacrolimus or cyclosporine) and low-dose corticosteroid. Additionally, recipients of blood-
type-incompatible liver grafts received preoperative anti-CD20 antibody (rituximab, 375 
mg/m2) with preoperative plasma exchange, postoperative hepatic artery infusion of 
prostaglandin E1 (0.01 µg/kg/min) and methylprednisolone (125 mg/day), and postoperative 
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cyclophosphamide (2 mg/kg/day), followed by mycophenolate mofetil (starting dose, 500 
mg/day; maintenance dose, 1000 mg/day). 
 
Data collection 
The following patient and perioperative variables were obtained from patients’ medical 
records: patient characteristics (age, gender, height, weight, etiology of liver disease, 
preoperative laboratory test results, and Child–Pugh classification), operative variables (re-
transplantation, intraoperative blood loss, graft-to-recipient weight ratio, blood-type 
compatibility, and cold and warm ischemia times), and postoperative course [urine output, 
laboratory test results, postoperative hemodialysis, durations of postoperative intensive care 
unit (ICU) and hospital stays, and in-hospital mortality].  
 
Outcomes 
The primary outcome was AKI defined as any stage of AKI according to the Kidney Disease: 
Improving Global Outcomes guidelines [16]. The AKI stages were based on the serum 
creatinine (SCr) concentration measured daily for 7 days after surgery and urine output 
measured every 2 h during the postoperative ICU stay (for 7 days after surgery if the 
postoperative ICU stay continues longer than 7 days). The most recent SCr level measured 
before the surgery was used as the baseline value. 
 
Statistical analyses 
Continuous variables were presented as medians (interquartile range) and compared using the 
Mann–Whitney U test; categorical variables were presented as numbers (percentage) and 
compared using the Pearson chi-square test or Fisher exact test, as appropriate. We applied 
multivariable logistic regression analysis to determine the independent predictors of 
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postoperative AKI. On the basis of clinical relevance and a literature search for factors shown 
to be associated with AKI after adult liver transplantation, 12 variables [age, gender, 
preoperative laboratory test results (estimated glomerular filtration rate, serum albumin, 
prothrombin activity, and total bilirubin), hepatic encephalopathy, ascites, re-transplantation, 
intraoperative blood loss, graft-to-recipient weight ratio, and warm ischemia time] were 
considered for entry into the model [3–13]. Multicollinearity among variables was assessed 
by the variance inflation factor with a reference value of 10. A stepwise method combined 
with a bootstrap procedure [17] was used for variable selection. After considering all 
variables, a stepwise (forward and backward) variable selection minimizing Akaike 
information criteria was repeated for each of the 1000 bootstrap resamplings, and variables 
selected in 50% or more of the bootstrap models were retained in the final model. The 
discrimination and the calibration of the model were assessed using the c-statistic and the 
Hosmer–Lemeshow goodness-of-fit test, respectively. The primary multivariable analysis 
was based on data from patients for whom complete information on all variables was 
available. Sensitivity analyses were performed with the use of multiple imputation by chained 
equations. Missing values were imputed conditional on the non-missing values of the other 
variables including age, gender, estimated glomerular filtration rate, serum albumin, 
prothrombin activity, total bilirubin, hepatic encephalopathy, ascites, re-transplantation, 
intraoperative blood loss, graft-to-recipient weight ratio, warm ischemia time, and the 
presence or absence of AKI. For each outcome, multiple imputation results were obtained 
from 100 imputed datasets. 
Time-to-event analyses were used to compare the lengths of ICU and hospital stays. Patient 
data were censored at the time of death. Medians and interquartile ranges were obtained using 
Kaplan–Meier analyses, and the log-rank test was used to assess differences between groups. 
The sample size was determined by including all cases during the study period to maximize 
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the power. Previous studies suggested that at least 8–10 events per variable were required for 
reliable multivariable logistic regression analysis [18,19]. We assumed 20 eligible surgeries 
per year and predicted the prevalence of AKI to be 33%–78% on the basis of published 
reports concerning adult liver transplantation. Thus, we estimated that we could conduct 
multivariable logistic regression with 6–14 variables using our dataset. 
All statistical tests were two tailed, and a P value of <0.05 was considered to be statistically 







A total of 165 pediatric patients underwent liver transplantation during the study period. Of 
these, 156 subjects were analyzed, after excluding eight patients who had preoperative end-
stage renal disease and one patient whose data on postoperative urine output were missing 
and, therefore, for whom the presence or absence of AKI could not be judged. Only one case 
of cadaveric liver transplantation was included; all others were living donor liver 
transplantations. The median age of the study participants was 2 years (interquartile range: 0–
6); 90 patients (57.7%) were female. AKI occurred in 72 patients (46.2%); 34 (21.8%) had 
Stage 1, 32 (20.5%) had Stage 2, and 6 (3.8%) had Stage 3 AKI. AKI defined according to 
the SCr level alone developed in 53 patients (34.0%), and AKI defined according to urine 
output alone developed in 35 patients (22.4%). In 19 of the 35 patients (54.3%) who met the 
urine output criterion for AKI, the diagnosis of AKI would have been missed if only the SCr 
criterion had been used (Figure 1). 
Univariable associations between perioperative characteristics and postoperative AKI are 
presented in Table 1. Variables significantly associated at the 5% level were preoperative 
prothrombin activity, preoperative total bilirubin, and intraoperative blood loss. 
One hundred forty-three patients were included in the multivariable logistic regression 
analysis after excluding 13 patients (8.3%) with missing variables. After stepwise variable 
selection with bootstrap resampling, preoperative total bilirubin and intraoperative blood loss 
were chosen in more than 50% of resamples (preoperative total bilirubin: 72.6%; 
intraoperative blood loss: 57.0%) and included in the final model. In the final multivariable 
model, increased preoperative total bilirubin level and increased intraoperative blood loss 
were independently associated with the development of AKI (Table 2). None of the variance 
inflation factor values were greater than 10, indicating that there was no multicollinearity. 
The final model had acceptable discrimination (c-statistic: 0.651; 95% confidence interval: 
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0.559–0.742) and calibration (Hosmer–Lemeshow statistic P value: 0.472). When using 
multiple imputation to account for missing values, the point estimates for the associations 
were not substantially affected; the adjusted odds ratio for total bilirubin was 1.04 (95% 
confidence interval: 1.01–1.08; P = 0.024) and that for intraoperative blood loss was 1.02 
(95% confidence interval: 0.99–1.06; P = 0.108). 
We assessed the association of AKI with the lengths of ICU and hospital stays and in-hospital 
mortality. There was no significant difference in ICU stay between patients with and without 
AKI [median (interquartile range): 4 (4–5) vs. 4 (4–5) days; P = 0.094; Figure 2A], whereas 
AKI was significantly associated with prolonged hospitalization [median (interquartile 
range): 61 (44–100) vs. 46 (35–78) days; P = 0.028; Figure 2B]. We could not find a 
significant association between AKI and in-hospital mortality (4.2% in patients with AKI and 
3.6% in those without; P = 1.000). Clinical outcomes stratified by AKI stages or AKI 





In this retrospective study of 156 children aged between 3 months and 18 years who 
underwent liver transplantation, we found that the incidence of postoperative AKI according 
to recent guidelines was 46.2%. In addition, increased preoperative total bilirubin 
concentration and increased intraoperative blood loss were independently associated with the 
development of AKI. AKI was significantly associated with a prolonged hospital stay. 
To the best of our knowledge, this is the first study to investigate the incidence of 
postoperative AKI after pediatric liver transplantation. Children are assumed to have a low 
prevalence of chronic diseases such as diabetes mellitus and chronic kidney disease, both of 
which have been shown to be risk factors for AKI after liver transplantation [1,5–8]. In our 
study, only one patient had diabetes mellitus and no patient had preoperative renal 
insufficiency with an estimated glomerular filtration rate of <60 mL/min/1.73 m2. Despite 
these low prevalences of risk factors, the incidence of AKI in the current study (46.2%) was 
similar to that reported in adult liver transplantation (39.4%–56.6%) [3,20,21]. The common 
occurrence of AKI reinforces the need for systematic surveillance for AKI after pediatric liver 
transplantation. 
Compared with applying the SCr criterion alone, incorporating oliguria into the diagnostic 
criteria increased the measured incidence of AKI from 34.0% to 46.2%. Assessment of AKI 
according to the SCr level alone failed to identify AKI in 54.3% of the patients with low urine 
output. These findings are similar to our previous study in adult liver transplantation patients 
wherein we demonstrated that 44.7% of patients with oliguria were missed when we 
diagnosed AKI using the SCr level alone [15]. Epidemiological study of AKI in critically ill 
children and young adults showed that low urine output without increased SCr conferred an 
increased risk for mortality [22]. Our findings reveal the importance of monitoring both the 
SCr level and the urine output. 
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One of the risk factors for AKI identified in our study was increased preoperative total 
bilirubin level. This finding is in line with previous studies of AKI in adult liver transplant 
recipients, reporting that a high model for end-stage liver disease score or Child–Pugh score 
(both are calculated using the total bilirubin level) were independent risk factors for AKI 
[3,4,8–12]. Increased preoperative total bilirubin might reflect the severity of the underlying 
liver disease. Intraoperative blood loss was also found to be an independent risk factor for 
postoperative AKI in our study, as was shown in previous studies in adult liver transplant 
recipients [6,9,13]. Blood loss appears to be a surrogate marker for surgical complexity or 
intraoperative adverse events, and hemodynamic instability or anemia due to massive 
bleeding might reduce oxygen delivery to the kidneys and cause kidney injury. 
Prolonged hospitalization of patients with AKI might suggest that the postoperative course of 
these patients is complicated, although this finding is merely an association and cannot imply 
a causal relationship. Because in-hospital mortality in the study participants was very low 
(3.8%), this study is underpowered to assess differences in mortality by AKI status. However, 
AKI was shown to be associated with poor outcomes including increased mortality in 
critically ill children [22] and children undergoing cardiac surgery [23–26]. 
Limitations of our study are as follows. This was a single-center study, which may reduce the 
generalizability of our results. Most patients in this study underwent living donor liver 
transplantation; we cannot confirm whether our findings can be extrapolated to pediatric 
patients undergoing cadaveric liver transplantation. We used urine output measured every 2 h 
instead of every hour to define AKI, because urine output measurement is performed every 2 
h at our ICU; this modification of the definition of AKI might have affected the incidence of 
AKI. 
In conclusion, the incidence of postoperative AKI after pediatric liver transplantation was 
46.2%. Increased preoperative total bilirubin level and increased intraoperative blood loss 
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were independently associated with the development of AKI. AKI was significantly 
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Table 1. Univariable association between perioperative characteristics and postoperative AKI 
Variables All patients (n = 156) 
Acute kidney injury 
P value 
Absent (n = 84) Present (n = 72) 
Age (years) 2 (0–6) 2 (0–6) 1 (0–8) 0.514 
Female gender 90 (57.7%) 48 (57.1%)  42 (58.3%) 1.000 
Height (cm) 81 (66–113)  85 (67–110) 72 (65–118) 0.402 
Weight (kg) 11 (7–21)  12 (7–20) 9 (7–22) 0.683 
Etiology    0.888 
   Biliary atresia 112 (71.8%) 60 (71.4%) 52 (72.2%)  
   Metabolic liver disease 9 (5.8%) 6 (7.1%) 3 (4.2%)  
   Hepatic malignancy 8 (5.1%) 5 (6.0%) 3 (4.2%)  
   Acute liver failure 2 (1.3%) 1 (1.2%) 1 (1.4%)  
   Others 25 (16.0%) 12 (14.3%) 13 (18.1%)  
Child–Pugh classification (A/B/C) 30/72/54 19/42/23 11/30/31 0.115 
Ascites 49 (31.4%) 23 (27.4%) 26 (36.1%) 0.300 
Encephalopathy 6 (3.8%) 2 (2.4%) 4 (5.6%) 0.416 
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Preoperative serum creatinine (mg/dL) 0.20 (0.14–0.30) 0.20 (0.20–0.30) 0.20 (0.10–0.27) 0.070 
Preoperative estimated glomerular 
filtration rate (mL/min/1.73 m2) 
230.7 (163.9–286.6) 221.8 (159.8–273.2) 242.0 (175.3–293.1) 0.121 
Preoperative serum albumin (g/dL) 3.2 (2.7–3.7) 3.2 (2.7–3.6) 3.1 (2.7–3.7) 0.813 
Preoperative prothrombin activity (%) 65 (51–83) 69 (53–89) 63 (43–73) 0.017 
Preoperative international normalized 
ratio of prothrombin time 
1.31 (1.11–1.59) 1.25 (1.06–1.52) 1.37 (1.22–1.70) 0.008 
Preoperative total bilirubin (mg/dL) 7.7 (1.3–16.2) 4.6 (1.1–13.5) 9.7 (2.7–21.5) 0.006 
Re-transplantation 15 (9.6%) 5 (6.0%)  10 (13.9%)  0.109 
Blood loss (mL/kg) 87.8 (47.4–143.9) 75.5 (41.6–121.5) 106.0 (50.9–188.1) 0.026 
Graft-to-recipient weight ratio (%) 2.47 (1.43–3.43) 2.43 (1.43–3.36) 2.65 (1.55–3.43) 0.976 
ABO incompatible 30 (19.2%) 19 (22.6%)  11 (15.3%)  0.309 
Cold ischemia time (min) 85 (54–138) 80 (54–126) 91 (55–156) 0.202 
Warm ischemia time (min) 38 (33–44) 39 (35–45) 38 (31–42) 0.158 
Height was missing in 1 patient with AKI and 3 without AKI, and estimated glomerular filtration rate could not be calculated in these patients; 
blood loss was missing in 5 patients with AKI and 3 without AKI; graft-to-recipient weight ratio was missing in 4 patients with AKI and 3 without 
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AKI; cold ischemia time was missing in 6 patients with AKI and 4 without AKI; warm ischemia time was missing in 6 patients with AKI and 3 




Table 2. Independent risk factors for acute kidney injury 
  Adjusted odds ratio (95% confidence interval) P value 
Preoperative total bilirubin (per 1 mg/dL) 1.04 (1.01–1.09) 0.026  








Figure 1. Venn diagram of AKI status based on SCr or urine output criteria. AKI, acute kidney 






Figure 2. The lengths of ICU (A) and hospital (B) stays according to AKI status. ICU, intensive 
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Supplemental data 1 
Clinical outcomes stratified by AKI stages or AKI definitions 
 
Table 1. Clinical outcomes stratified by AKI stages 
  
No AKI 
(n = 84) 
Stage 1 AKI 
(n = 34) 
Stage 2 AKI 
(n = 32) 
Stage 3 AKI 
(n = 6) P value 
Time to discharge 
(days)      
   From ICU 4 (4–5) 4 (3–5) 5 (4–5) 5 (4–5) 0.088 
   From hospital 46 (35–78) 59 (43–80) 64 (52–106) 61 (44–76) 0.154 
In-hospital mortality 3 (3.6%) 0 (0.0%) 2 (6.3%) 1 (16.6%) 0.141 
Data are medians (interquartile range) or numbers (percentage). AKI, acute kidney injury; 
ICU, intensive care unit. 
 
Table 2. Clinical outcomes stratified by AKI definitions 
  
No AKI 
(n = 84) 
AKI-Cr only 
(n = 37) 
AKI-UO only 
(n = 19) 
AKI-Cr and 
AKI-UO 
(n = 16) P value 
Time to discharge 
(days)           
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   From ICU 4 (4–5) 4 (3–5) 4 (4–5) 5 (4–7) 0.050  
   From hospital 46 (35–78) 63 (43–79) 50 (42–105) 65 (55–110) 0.098  
In-hospital mortality 3 (3.6%) 2 (5.4%) 0 (0.0%) 1 (6.3%) 0.603  
Data are medians (interquartile range) or numbers (percentage). AKI, acute kidney injury; 
ICU, intensive care unit; AKI-Cr, acute kidney injury defined based on serum creatinine 
criterion; AKI-UO, acute kidney injury defined based on urine output criterion. 
 
